Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT02334007
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT02334007
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02334007. Randomized; quadruple masking; primary purpose prevention. Start 2015-09 (registry gives no type); primary completion 2018-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
- Condition
- Venous Thromboembolism
- Condition
- Lung Neoplasms
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- LMWH: Dalteparin
- Intervention (Other)
- Placebo
- Lead sponsor
- McMaster University
Record details
- Record id
cardio:ct-nct02334007- Content hash
dd70284344aa6560b27f6cfe7f8c24485cb337a43d621bc6b66d90d28d6f117e